Orasis Pharmaceuticals

Verified

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Company News Orasis Pharmaceuticals Team Profile Healthcare Startups Series C Route Israel News

About Orasis Pharmaceuticals

Orasis Pharmaceuticals is tracked on 100Xfounder as a healthcare company, founded in 2015, based in Tel Aviv, Israel, currently mapped to the Series C stage. Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Profile snapshot: Founders linked: Orasis Pharmaceuticals Team. Funding tracked: $30.00M. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

Orasis Pharmaceuticals appears in the 100Xfounder startup directory import feed.

Why it Matters

Orasis Pharmaceuticals is worth tracking because its funding history is already mapped here, including a $30.00M round, recent coverage is already tied back to this page, and Orasis Pharmaceuticals Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $30.00MLast Round: Series C Sequoia, $30M Series C in 2020All Rounds: 1

Series C | Sequoia, $30M Series C in 2020

Hiring Roles

No active hiring signal detected.

Meet the Founders

Orasis Pharmaceuticals Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

PythonGCPBigQueryReact

Last updated: June 1, 2026

Orasis Pharmaceuticals research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical
Founders covered
Orasis Pharmaceuticals Team
Market position
Healthcare | Series C | Tel Aviv, Israel
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$30.00M

Best next clicks

Company News Hub Orasis Pharmaceuticals Team Israel News Healthcare Startups Series C Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Thatch

Thatch Team

View Company Industry Hub

Tempo

Tempo Team

View Company Industry Hub

Neuralink

Neuralink Team

View Company Industry Hub

Cedar

Cedar Team

View Company Industry Hub

SWORD Health

SWORD Health Team

View Company Industry Hub

Scipher Medicine

Scipher Medicine Team

View Company Industry Hub

Calibrate

Calibrate Team

View Company Industry Hub

Forward

Forward Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to Orasis Pharmaceuticals.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→Israel startup directory→Healthcare hub→Healthcare startup list→Series C startup list→Series C newsroom→Healthcare startups in Israel→Founder directory→Startup directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Orasis Pharmaceuticals

Common questions people ask about this profile.

What is Orasis Pharmaceuticals?

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses. Healthcare Medical

Who founded Orasis Pharmaceuticals?

Orasis Pharmaceuticals is associated with Orasis Pharmaceuticals Team on 100Xfounder.

Where is Orasis Pharmaceuticals located?

Orasis Pharmaceuticals is listed in Tel Aviv, Israel.

What stage is Orasis Pharmaceuticals in?

Orasis Pharmaceuticals is currently mapped to Series C. Funding context: Sequoia, $30M Series C in 2020

What is the latest funding round of Orasis Pharmaceuticals?

Orasis Pharmaceuticals's latest tracked round is Series C Sequoia, $30M Series C in 2020. Total tracked rounds: 1.

Is Orasis Pharmaceuticals hiring now?

Orasis Pharmaceuticals hiring status: no active hiring signal.

What technologies does Orasis Pharmaceuticals use?

Orasis Pharmaceuticals is associated with Python, GCP, BigQuery, and React.

Is Orasis Pharmaceuticals verified on 100Xfounder?

Yes. Orasis Pharmaceuticals is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Orasis Pharmaceuticals founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.